208 related articles for article (PubMed ID: 22583416)
21. New MDR modulators and apoptosis inducers from Euphorbia species.
Engi H; Vasas A; Rédei D; Molnár J; Hohmann J
Anticancer Res; 2007; 27(5A):3451-8. PubMed ID: 17970094
[TBL] [Abstract][Full Text] [Related]
22. Designed P-glycoprotein inhibitors with triazol-tetrahydroisoquinoline-core increase doxorubicin-induced mortality in multidrug resistant K562/A02 cells.
Kairuki M; Qiu Q; Pan M; Li Q; Zhou J; Ghaleb H; Huang W; Qian H; Jiang C
Bioorg Med Chem; 2019 Aug; 27(15):3347-3357. PubMed ID: 31202598
[TBL] [Abstract][Full Text] [Related]
23. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
24. 3-benzazecine-based cyclic allene derivatives as highly potent P-glycoprotein inhibitors overcoming doxorubicin multidrug resistance.
Titov AA; Niso M; Candia M; Kobzev MS; Varlamov AV; Borisova TN; Voskressensky LG; Colabufo NA; Cellamare S; Pisani L; Altomare CD
Future Med Chem; 2019 Aug; 11(16):2095-2106. PubMed ID: 31538529
[No Abstract] [Full Text] [Related]
25. New macrocyclic lathyrane diterpenes, from Euphorbia lagascae, as inhibitors of multidrug resistance of tumour cells.
Duarte N; Gyémánt N; Abreu PM; Molnár J; Ferreira MJ
Planta Med; 2006 Feb; 72(2):162-8. PubMed ID: 16491453
[TBL] [Abstract][Full Text] [Related]
26. Exploring Jolkinol D Derivatives To Overcome Multidrug Resistance in Cancer.
Reis MA; Ahmed OB; Spengler G; Molnár J; Lage H; Ferreira MU
J Nat Prod; 2017 May; 80(5):1411-1420. PubMed ID: 28421773
[TBL] [Abstract][Full Text] [Related]
27. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
[TBL] [Abstract][Full Text] [Related]
28. A myrsinol diterpene isolated from
Chen X; Chen X; Liu X; Wink M; Ma Y; Guo Y
Pharmazie; 2016 Sep; 71(9):537-539. PubMed ID: 29441851
[TBL] [Abstract][Full Text] [Related]
29. Jatrophane diterpenoid esters from Euphorbia sororia serving as multidrug resistance reversal agents.
Lu D; Liu Y; Aisa HA
Fitoterapia; 2014 Jan; 92():244-51. PubMed ID: 24291755
[TBL] [Abstract][Full Text] [Related]
30. Euphorbia factor L1 reverses ABCB1-mediated multidrug resistance involving interaction with ABCB1 independent of ABCB1 downregualtion.
Zhang JY; Mi YJ; Chen SP; Wang F; Liang YJ; Zheng LS; Shi CJ; Tao LY; Chen LM; Chen HB; Fu LW
J Cell Biochem; 2011 Apr; 112(4):1076-83. PubMed ID: 21308736
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-oxo-3,4-dihydrophthalazine-1-carboxamide derivatives as novel P-glycoprotein inhibitors reversing multidrug resistance.
Qiu Q; Zhou J; Shi W; Kairuki M; Huang W; Qian H
Bioorg Chem; 2019 May; 86():166-175. PubMed ID: 30710850
[TBL] [Abstract][Full Text] [Related]
32. Diterpenes from Euphorbia piscatoria: synergistic interaction of Lathyranes with doxorubicin on resistant cancer cells.
Reis MA; Paterna A; Mónico A; Molnar J; Lage H; Ferreira MJ
Planta Med; 2014 Dec; 80(18):1739-45. PubMed ID: 25371982
[TBL] [Abstract][Full Text] [Related]
33. Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer.
Ludwig JA; Szakács G; Martin SE; Chu BF; Cardarelli C; Sauna ZE; Caplen NJ; Fales HM; Ambudkar SV; Weinstein JN; Gottesman MM
Cancer Res; 2006 May; 66(9):4808-15. PubMed ID: 16651436
[TBL] [Abstract][Full Text] [Related]
34. Diterpene Constituents of Euphorbia exigua L. and Multidrug Resistance Reversing Activity of the Isolated Diterpenes.
Rédei D; Boros K; Forgo P; Molnár J; Kele Z; Pálinkó I; Pinke G; Hohmann J
Chem Biodivers; 2015 Aug; 12(8):1214-21. PubMed ID: 26265573
[TBL] [Abstract][Full Text] [Related]
35. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
[No Abstract] [Full Text] [Related]
36. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
[TBL] [Abstract][Full Text] [Related]
37. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin.
Zong L; Cheng G; Liu S; Pi Z; Liu Z; Song F
J Pharm Biomed Anal; 2019 Feb; 165():268-275. PubMed ID: 30572191
[TBL] [Abstract][Full Text] [Related]
38. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
39. Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.
Qiu Q; Shi W; Li Z; Zhang B; Pan M; Cui J; Dai Y; Huang W; Qian H
J Med Chem; 2017 Apr; 60(7):2930-2943. PubMed ID: 28301155
[TBL] [Abstract][Full Text] [Related]
40. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
